- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Aaron Lee: AI in Ophthalmology Comes With Important Caveats
Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington, discusses some limitations of artificial intelligence (AI) in the ophthalmology field.
Artificial intelligence (AI) can't do the full spectrum of all the things a human clinician does today, said Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington.
Transcript
Can you discuss some of the pitfalls resulting from the transition to digital care in ophthalmology?
I do worry a little bit about the hype around AI, because so much of AI has elevated everybody's expectations. We expect AI to be able to drive our cars. We expect AI to keep airplanes in the air and all those kinds of things. And it is true that this technology, specifically deep learning, is a remarkable advancement in artificial intelligence. It is true that it is capable of some wondrous things, things that I thought were completely impossible before. But it comes with very important caveats.
They're very, very good at a very narrow window of things. So I think people may not understand, both clinicians as well as patients, that an AI algorithm being used in their care may only be useful in that very narrow context. Now, in that context, it may do an amazing job, but it can't do the full spectrum of all the things that a human clinician can do today.
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More
